Notch blockade overcomes endothelial cell-mediated resistance of FLT3/ITD-positive AML progenitors to AC220 treatment
- 8 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (2), 601-605
- https://doi.org/10.1038/s41375-020-0893-y
Abstract
No abstract availableFunding Information
- The Hartwell Fellowship Foundation
This publication has 15 references indexed in Scilit:
- Notch2 blockade enhances hematopoietic stem cell mobilization and homingHaematologica, 2017
- Notch Receptor-Ligand Engagement Maintains Hematopoietic Stem Cell Quiescence and Niche RetentionThe International Journal of Cell Cloning, 2015
- Metastasis prevention by targeting the dormant nicheNature Reviews Cancer, 2015
- The Notch Delta-4 ligand helps to maintain the quiescence and the short-term reconstitutive potential of haematopoietic progenitor cells through activation of a key gene networkStem Cell Research, 2014
- Activation of the vascular niche supports leukemic progression and resistance to chemotherapyExperimental Hematology, 2014
- Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemiaLeukemia, 2014
- Bone marrow stroma‐mediated resistance to FLT3 inhibitors in FLT3‐ITD AML is mediated by persistent activation of extracellular regulated kinaseBritish Journal of Haematology, 2013
- Therapeutic antibody targeting of individual Notch receptorsNature, 2010
- Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem CellsCell Stem Cell, 2010
- FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemiaBlood, 2006